Expanding the universe of new treatments for patients

Arrakis Therapeutics Appoints Patrizio Renzetti as Vice President of Human Resources

Waltham, MA – November 19, 2020 – Arrakis Therapeutics, a biopharmaceutical company pioneering the discovery of a new class of small molecule medicines that directly target RNA, today announced that Patrizio Renzetti has joined the company as Vice President, Human Resources. Patrizio is an experienced human resources leader with broad expertise at dynamic high-growth companies, both large and small, including Agios Pharmaceuticals, Lilly, and Procter & Gamble. In his role on the Arrakis management team, he will be responsible for all aspects of human resources and will be a key contributor to the company’s plans for continued growth.

“Patrizio is an ideal fit to lead the HR function at Arrakis, having built high-performing R&D organizations at fully integrated, global companies,” said Michael Gilman, Chief Executive Officer of Arrakis. “He has the experience, sophistication, and insight to help Arrakis attract and retain great people, develop our leaders, and strengthen our culture as we realize our vision to build a world-class organization that delivers breakthrough RNA-targeted medicines to patients.”

“It’s wonderful to join Arrakis at a time when the company is on the cusp of translating its innovation in RNA-targeted small molecules into a pipeline of potentially life-changing medicines,” said Patrizio Renzetti  “I am committed to help realize the company’s vision by ensuring that we create an exciting and stimulating environment for our people to be their best selves, leverage our core values, and invest in developing our talent. We will continue to cultivate what makes Arrakis a special place, with an inclusive culture that drives creative thinking, innovation, and focus on the patients we intend to serve.”

Patrizio has twenty years of human resources experience building cultures that attract, retain and develop world class talent at high-growth companies, including leading biopharmaceutical companies. He joins Arrakis from Agios Pharmaceuticals where he most recently served as Vice President of Human Resources for R&D, Technical Operations, and Europe, and previously led the Talent Acquisition group. He previously held HR leadership roles at Eli Lilly and Company, including in Global Clinical Development, the Diabetes Business Unit, and the Italian Manufacturing site. Earlier in his career, he served in several HR roles for Procter & Gamble in Italy.

About Arrakis Therapeutics

Arrakis Therapeutics is a biopharmaceutical company pioneering the discovery of a new class of medicines that directly target RNA. Arrakis is building a proprietary pipeline of RNA-targeted small molecule (rSM) medicines focused on cancer and genetically validated targets in other disease areas. The company brings together scientific leaders in RNA structure, chemistry and biology, along with a highly experienced management team and the backing of leading life sciences investors. The company is located in Waltham, Massachusetts. For more information, please visit www.arrakistx.com and engage with us on Twitter @ArrakisTx or on LinkedIn.

Media Contact:
Kathryn Morris
914-204-6412
[email protected]

Investor Contact:
Will O’Connor
212-362-1200
[email protected]